Kisspeptin

DB19112InvestigationalProtein Based Therapies

Kisspeptin is under investigation in clinical trial NCT03315325 (Age-dependent Changes in the Responsiveness of Hypothalamic Pituitary Gonadal Axis in Men).

Mechanism: Pharmacologically active on KiSS-1 receptor
Curator reviewed
Also known as: Kiss-1 metastasis suppressor · Metastin
Code names: KISS-1

Resolves to

Compound

UNII2VG74ZW2K5CAS388138-21-4

Targets

Q969F8KISS1R

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

18Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Kisspeptin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account